Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
NCT01394471
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
DRUG:
Intranasal Oxytocin Spray
Sponsor
University of North Carolina, Chapel Hill
Collaborators
[object Object]